VIVACAINE Drug Patent Profile
✉ Email this page to a colleague
When do Vivacaine patents expire, and what generic alternatives are available?
Vivacaine is a drug marketed by Septodont and is included in one NDA.
The generic ingredient in VIVACAINE is bupivacaine hydrochloride; epinephrine bitartrate. There are twelve drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride; epinephrine bitartrate profile page.
Summary for VIVACAINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 3 |
Formulation / Manufacturing: | see details |
DailyMed Link: | VIVACAINE at DailyMed |
Recent Clinical Trials for VIVACAINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Cairo University | Phase 2/Phase 3 |
Mayo Clinic | Phase 2 |
Mayo Clinic | Phase 4 |
Pharmacology for VIVACAINE
Drug Class | Amide Local Anesthetic Catecholamine alpha-Adrenergic Agonist beta-Adrenergic Agonist |
Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
Physiological Effect | Local Anesthesia |
Anatomical Therapeutic Chemical (ATC) Classes for VIVACAINE
US Patents and Regulatory Information for VIVACAINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Septodont | VIVACAINE | bupivacaine hydrochloride; epinephrine bitartrate | INJECTABLE;INJECTION | 077250-001 | Sep 27, 2006 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |